ACTIVE

PHARMACIE NIMAX

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result30,4 k €+103,8 %over 1 year
Gross margin113,1 k €+30,4 %over 1 year
Equity-399,8 k €+7,1 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE NIMAX is a Public limited company incorporated in 2006. Its main activity is: Activities of head offices; management consultancy activities. Its registered office is in Grez-Doiceau.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0882.213.317
Incorporation
28/06/2006
Legal form
Public limited company
Registered office
Rue de Hamme-Mille 28
1390 Grez-Doiceau · WallonieSee on map
Contributed capital
157 224,26 €
Latest accounts
31/12/2024
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 18 filings

Trend over 18 financial years

20242023202220212020
Income statement
Gross margin113,1 k €86,7 k €–––
EBITDA107 k €32 k €33,9 k €2,1 k €23,8 k €
Operating result71,4 k €8,5 k €16,6 k €-14,2 k €7,5 k €
Net result30,4 k €-795,7 k €14,4 k €-25,7 k €-880,4 €
Balance sheet
Equity-399,8 k €-430,2 k €365,5 k €351,1 k €376,9 k €
Total assets949,4 k €565,8 k €1,5 M €1,5 M €1,5 M €
Cash22,4 k €46,9 k €6,9 k €3,7 k €4 k €
Debts1,3 M €970,9 k €1,1 M €1,1 M €1,1 M €

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 17 ended

Active mandates

Carine Grzybowski

Director

Active
Claude Nimax

Director

Active

Ended mandates

Claude Ernest Nimax

Director · since 28 octobre 2016 · until 19 mai 2022

Ended
Jean-Michel Cambounet

Director · since 31 juillet 2011 · until 10 mai 2017

Ended
Jean-Michel Cambounet

Director · since 16 juillet 2011 · until 10 mai 2017

Ended
Alphar Partners

Director · since 01 juillet 2010 · until 30 juin 2016 · 0475.639.696

Represented by Peter Van Elslander

Ended

Full financial information

Source · NBB
202420232022202120202019
Type of accountMicro modelMicro modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202401/01/202301/01/202201/01/202101/01/202001/01/2019
Closing of the financial year31/12/202431/12/202331/12/202231/12/202131/12/202031/12/2019
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date29/09/202513/08/202411/08/202310/08/202222/09/202104/09/2020
General meeting15/05/202516/05/202418/05/202319/05/202220/05/202121/05/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 18 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202415/05/202529/09/2025FrenchPDF
Micro model31/12/202316/05/202413/08/2024FrenchPDF
Full model31/12/202218/05/202311/08/2023FrenchPDF
Full model31/12/202119/05/202210/08/2022FrenchPDF
Full model31/12/202020/05/202122/09/2021FrenchPDF
Full model31/12/201921/05/202004/09/2020FrenchPDF
Full model31/12/201816/05/201930/09/2019FrenchPDF
Full model31/12/201717/05/201820/08/2018FrenchPDF
Full model31/12/201615/06/201727/06/2017FrenchPDF
Full model31/12/201530/05/201609/06/2016FrenchPDF
Full model31/12/201430/06/201514/07/2015FrenchPDF
Full model31/12/201315/05/201420/05/2014FrenchPDF
Full model31/12/201216/05/201324/06/2013FrenchPDF
Full model31/12/201118/05/201201/06/2012FrenchPDF
Full model31/12/201009/06/201120/06/2011FrenchPDF
Full model31/12/200930/06/201030/08/2010FrenchPDF
Full model31/12/200825/07/200929/07/2009FrenchPDF
Full model31/12/200715/05/200811/06/2008FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 17 ended

Active mandates

Carine Grzybowski

Director

Active
Claude Nimax

Director

Active

Ended mandates

Claude Ernest Nimax

Director · since 28 octobre 2016 · until 19 mai 2022

Ended
Jean-Michel Cambounet

Director · since 31 juillet 2011 · until 10 mai 2017

Ended
Jean-Michel Cambounet

Director · since 16 juillet 2011 · until 10 mai 2017

Ended
Alphar Partners

Director · since 01 juillet 2010 · until 30 juin 2016 · 0475.639.696

Represented by Peter Van Elslander

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Restructuring27/06/2023
    DENOMINATION - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Mandates28/04/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Restructuring31/03/2023
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
    PDF
  • Mandates03/02/2017
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates23/11/2016
    DENOMINATION - CAPITAL, ACTIONS
    PDF
  • Mandates16/11/2016
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates23/06/2016
    DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
    PDF
  • Mandates08/07/2013
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 202430,4 k €↑
  2. 2024
    Name changePHARMACIE NIMAX
  3. 2023
    Annual accounts 2023-795,7 k €↓
  4. 2022
    Annual accounts 202214,4 k €↑
  5. 2021
    Annual accounts 2021-25,7 k €↓
  6. 2021
    Name changeNETHEN sa
  7. 2020
    Annual accounts 2020-880,4 €↓
  8. 2019
    Annual accounts 2019-742,8 €↓
  9. 2018
    Annual accounts 20182,3 k €↓
  10. 2017
    Annual accounts 20172,4 k €↓
  11. 2016
    Annual accounts 20161,4 M €↑
  12. 2015
    Annual accounts 2015-1,2 M €↓
  13. 2014
    Annual accounts 2014-26 k €↓
  14. 2013
    Annual accounts 2013-8,5 k €↓
  15. 2012
    Annual accounts 2012-3,5 k €↑
  16. 2011
    Annual accounts 2011-54,4 k €↓
  17. 2010
    Annual accounts 2010-39,9 k €↓
  18. 2009
    Annual accounts 2009-38,6 k €↑
  19. 2008
    Annual accounts 2008-42,9 k €↑
  20. 2007
    Annual accounts 2007-57,6 k €
  21. 28/06/2006
    IncorporationPublic limited company